Evening Business Interview for 24 May 2011

The listed biomedical firm, Pacific Edge, has struck a major deal to license its world-first bladder cancer test in Spain and Portugal. The Dunedin-based company has signed up the biotechnology and molecular diagnostics firm, Oryzon, to market its Cxbladder urine test to urologists and GPs.